Cash Trading
U.S. cash products handled average daily volume (“ADV”) decreased 8.9% to 3.5 billion shares2.
-
Total
NYSE -listed (Tape A) consolidated volume increased 8.3% to 5.4 billion shares. -
NYSE -listed matched volume (Tape A) decreased 13.8% to 2.3 billion shares. -
Tape A matched market share was 42.3%, compared to 43.4% in
December 2008 and 58.4% inJanuary 2008 . -
Designated Market Maker (DMM) participation in
January 2009 was 8.4%, the highest level of participation sinceFebruary 2006 , and up from 7% inDecember 2008 . The increased level of participation was driven in part by the introduction of the NYSE’s new market model inOctober 2008 . - Total NYSE Arca and NYSE Amex-listed consolidated volume (Tape B) increased 60.4% to 2.0 billion shares.
- NYSE’s matched volume of Tape B increased 38.4% to 540 million shares.
- Total Nasdaq-listed (Tape C) consolidated volume decreased 23.8% to 2.1 billion shares.
- NYSE’s matched volume of Tape C decreased 26.6% to 324 million shares.
-
Tape C matched market share was relatively stable at 15.8%, compared
to 15.6% in
December 2008 and 16.4% inJanuary 2008 . - Exchange-traded funds matched volume (included in the trading volume numbers above) increased 24.8% to 535 million shares.
European cash products ADV decreased 29.5% to 1.3 million transactions2
from 1.9 million transactions in
- European cash trading activity qualifying for Pack Epsilon pricing represented 35% of total transactions executed.
Derivatives Trading
European derivatives products ADV was 3.8 million futures and options
contracts, a decrease of 18.4% from
-
Total interest rate products ADV decreased 32.1% to 2.0 million
contracts from 2.9 million contracts in
January 2008 , which was the highest monthly ADV ever for interest rate products. - Total equity products (including Bclear) ADV increased 5.6% to 1.8 million contracts. Bclear, NYSE Liffe's trade administration and clearing service, processed 779 thousand contracts per day, an increase of 98.2%.
U.S. equity options ADV decreased 13.7% to 2.1 million contracts. Total
consolidated options ADV declined 23.5% to 12.0 million contracts.
Please click here for the Monthly Transaction Activity Data Table.
About
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements include,
but are not limited to, statements concerning NYSE Euronext’s plans,
objectives, expectations and intentions and other statements that are
not historical or current facts. Forward-looking statements are based on
NYSE Euronext’s current expectations and involve risks and uncertainties
that could cause actual results to differ materially from those
expressed or implied in such forward-looking statements. Factors that
could cause NYSE Euronext’s results to differ materially from current
expectations include, but are not limited to: NYSE Euronext’s ability to
implement its strategic initiatives, economic, political and market
conditions and fluctuations, government and industry regulation,
interest rate risk and U.S. and global competition, and other factors
detailed in NYSE Euronext’s reference document for 2007 ("document de
référence") filed with the French Autorité des Marchés Financiers
(Registered on
1 All comparisons versus
2 Euronext equities transactions count each buy and sell
order as separate transactions,
NYSE Euronext | |||||||||||||||||||||||
Monthly Volume Summary - Cash Products |
|||||||||||||||||||||||
Average Daily Volume | Total Volume | Total Volume | |||||||||||||||||||||
(Unaudited) | Jan-09 | Jan-08 | % Chg | Jan-09 | Jan-08 | % Chg | YTD 2009 |
% Chg vs. |
|||||||||||||||
Number of Trading Days - European Markets | 21 | 22 | 21 | 22 | 21 | ||||||||||||||||||
Number of Trading Days - U.S. Markets | 20 | 21 | 20 | 21 | 20 | ||||||||||||||||||
European Cash Products (trades in thousands) | 1,329 | 1,886 | -29.5 | % | 27,918 | 41,501 | -32.7 | % | 27,918 | -32.7 | % | ||||||||||||
Equities | 1,264 | 1,821 | -30.6 | % | 26,542 | 40,052 | -33.7 | % | 26,542 | -33.7 | % | ||||||||||||
Exchange-Traded Funds | 13 | 11 | 16.2 | % | 275 | 248 | 10.9 | % | 275 | 10.9 | % | ||||||||||||
Structured Products | 47 | 48 | -2.1 | % | 996 | 1,065 | -6.5 | % | 996 | -6.5 | % | ||||||||||||
Bonds | 5 | 6 | -18.8 | % | 106 | 137 | -22.5 | % | 106 | -22.5 | % | ||||||||||||
U.S. Cash Products (shares in millions) 2 | 3,540 | 3,885 | -8.9 | % | 70,790 | 81,580 | -13.2 | % | 70,790 | -13.2 | % | ||||||||||||
NYSE Listed (Tape A) Issues 1 | |||||||||||||||||||||||
NYSE Group Handled Volume 2 | 2,520 | 2,894 | -12.9 | % | 50,390 | 60,780 | -17.1 | % | 50,390 | -17.1 | % | ||||||||||||
NYSE Group Matched Volume 3 | 2,271 | 2,634 | -13.8 | % | 45,430 | 55,311 | -17.9 | % | 45,430 | -17.9 | % | ||||||||||||
NYSE Group TRF Volume 4 | 9 | 208 | -95.6 | % | 184 | 4,359 | -95.8 | % | 184 | -95.8 | % | ||||||||||||
Total NYSE Listed Consolidated Volume | 5,370 | 4,959 | 8.3 | % | 107,394 | 104,149 | 3.1 | % | 107,394 | 3.1 | % | ||||||||||||
NYSE Group Share of Total Consolidated Volume | |||||||||||||||||||||||
Handled Volume 2 | 46.9 | % | 58.4 | % | -11.5 | % | 46.9 | % | 58.4 | % | -11.5 | % | 46.9 | % | -11.5 | % | |||||||
Matched Volume 3 | 42.3 | % | 53.1 | % | -10.8 | % | 42.3 | % | 53.1 | % | -10.8 | % | 42.3 | % | -10.8 | % | |||||||
TRF Volume 4 | 0.2 | % | 4.2 | % | -4.0 | % | 0.2 | % | 4.2 | % | -4.0 | % | 0.2 | % | -4.0 | % | |||||||
NYSE Arca & Alternext US (Tape B) Listed Issues | |||||||||||||||||||||||
NYSE Group Handled Volume 2 | 622 | 454 | 37.0 | % | 12,445 | 9,540 | 30.4 | % | 12,445 | 30.4 | % | ||||||||||||
NYSE Group Matched Volume 3 | 540 | 390 | 38.4 | % | 10,802 | 8,197 | 31.8 | % | 10,802 | 31.8 | % | ||||||||||||
NYSE Group TRF Volume 4 | 1 | 85 | -98.8 | % | 21 | 1,788 | -98.8 | % | 21 | -98.8 | % | ||||||||||||
Total NYSE Arca & Amex Listed Consolidated Volume | 2,037 | 1,269 | 60.4 | % | 40,736 | 26,658 | 52.8 | % | 40,736 | 52.8 | % | ||||||||||||
NYSE Group Share of Total Consolidated Volume | |||||||||||||||||||||||
Handled Volume 2 | 30.6 | % | 35.8 | % | -5.2 | % | 30.6 | % | 35.8 | % | -5.2 | % | 30.6 | % | -5.2 | % | |||||||
Matched Volume 3 | 26.5 | % | 30.7 | % | -4.2 | % | 26.5 | % | 30.7 | % | -4.2 | % | 26.5 | % | -4.2 | % | |||||||
TRF Volume 4 | 0.1 | % | 6.7 | % | -6.6 | % | 0.1 | % | 6.7 | % | -6.6 | % | 0.1 | % | -6.6 | % | |||||||
Nasdaq Listed (Tape C) Issues | |||||||||||||||||||||||
NYSE Group Handled Volume 2 | 398 | 536 | -25.8 | % | 7,955 | 11,260 | -29.3 | % | 7,955 | -29.3 | % | ||||||||||||
NYSE Group Matched Volume 3 | 324 | 441 | -26.6 | % | 6,474 | 9,257 | -30.1 | % | 6,474 | -30.1 | % | ||||||||||||
NYSE Group TRF Volume 4 | 7 | 203 | -96.4 | % | 148 | 4,257 | -96.5 | % | 148 | -96.5 | % | ||||||||||||
Total Nasdaq Listed Consolidated Volume | 2,051 | 2,691 | -23.8 | % | 41,011 | 56,502 | -27.4 | % | 41,011 | -27.4 | % | ||||||||||||
NYSE Group Share of Total Consolidated Volume | |||||||||||||||||||||||
Handled Volume 2 | 19.4 | % | 19.9 | % | -0.5 | % | 19.4 | % | 19.9 | % | -0.5 | % | 19.4 | % | -0.5 | % | |||||||
Matched Volume 3 | 15.8 | % | 16.4 | % | -0.6 | % | 15.8 | % | 16.4 | % | -0.6 | % | 15.8 | % | -0.6 | % | |||||||
TRF Volume 4 | 0.4 | % | 7.5 | % | -7.1 | % | 0.4 | % | 7.5 | % | -7.1 | % | 0.4 | % | -7.1 | % | |||||||
Exchange-Traded Funds 1,5 | |||||||||||||||||||||||
NYSE Group Handled Volume 2 | 617 | 497 | 24.2 | % | 12,339 | 10,430 | 18.3 | % | 12,339 | 18.3 | % | ||||||||||||
NYSE Group Matched Volume 3 | 535 | 429 | 24.8 | % | 10,708 | 9,010 | 18.8 | % | 10,708 | 18.8 | % | ||||||||||||
NYSE Group TRF Volume 4 | 1 | 104 | -99.3 | % | 15 | 2,178 | -99.3 | % | 15 | -99.3 | % | ||||||||||||
Total ETF Consolidated Volume | 2,060 | 1,391 | 48.1 | % | 41,195 | 29,215 | 41.0 | % | 41,195 | 41.0 | % | ||||||||||||
NYSE Group Share of Total Consolidated Volume | |||||||||||||||||||||||
Handled Volume 2 | 30.0 | % | 35.7 | % | -5.7 | % | 30.0 | % | 35.7 | % | -5.7 | % | 30.0 | % | -5.8 | % | |||||||
Matched Volume 3 | 26.0 | % | 30.8 | % | -4.8 | % | 26.0 | % | 30.8 | % | -4.8 | % | 26.0 | % | -4.8 | % | |||||||
TRF Volume 4 | 0.0 | % | 7.5 | % | -7.5 | % | 0.0 | % | 7.5 | % | -7.5 | % | 0.0 | % | -7.5 | % |
NYSE Euronext |
||||||||||||||||||||||||
Monthly Volume Summary - Derivatives Products |
||||||||||||||||||||||||
Average Daily Volume | Total Volume | Total Volume | ||||||||||||||||||||||
(Unaudited; contracts in thousands) | Jan-09 | Jan-08 | % Chg | Jan-09 | Jan-08 | % Chg | YTD 2009 |
% Chg vs. |
||||||||||||||||
Number of Trading Days - European Markets | 21 | 22 | 21 | 22 | 21 | |||||||||||||||||||
Number of Trading Days - U.S. Markets | 20 | 21 | 20 | 21 | 20 | |||||||||||||||||||
European Derivatives Products | 3,826 | 4,691 | -18.4 | % | 80,349 | 103,192 | -22.1 | % | 80,349 | -22.1 | % | |||||||||||||
Total Interest Rate Products 6 | 1,989 | 2,927 | -32.1 | % | 41,760 | 64,399 | -35.2 | % | 41,760 | -35.2 | % | |||||||||||||
Short Term Interest Rate Products | 1,911 | 2,829 | -32.5 | % | 40,127 | 62,235 | -35.5 | % | 40,127 | -35.5 | % | |||||||||||||
Medium and Long Term Interest Rate Products | 78 | 98 | -20.9 | % | 1,633 | 2,164 | -24.5 | % | 1,633 | -24.5 | % | |||||||||||||
Total Equity Products 7 | 1,793 | 1,698 | 5.6 | % | 37,655 | 37,357 | 0.8 | % | 37,655 | 0.8 | % | |||||||||||||
Individual Equity Products | 1,196 | 894 | 33.8 | % | 25,124 | 19,673 | 27.7 | % | 25,124 | 27.7 | % | |||||||||||||
Equity Index Products | 597 | 804 | -25.8 | % | 12,532 | 17,684 | -29.1 | % | 12,532 | -29.1 | % | |||||||||||||
of which Bclear | 779 | 393 | 98.2 | % | 16,363 | 8,647 | 89.2 | % | 16,363 | 89.2 | % | |||||||||||||
Individual Equity Products | 650 | 268 | 142.6 | % | 13,653 | 5,895 | 131.6 | % | 13,653 | 131.6 | % | |||||||||||||
Equity Index Products | 129 | 125 | 3.2 | % | 2,711 | 2,752 | -1.5 | % | 2,711 | -1.5 | % | |||||||||||||
Commodity Products | 44 | 65 | -31.8 | % | 934 | 1,436 | -34.9 | % | 934 | -34.9 | % | |||||||||||||
U.S. Derivatives Products | ||||||||||||||||||||||||
U.S. Derivatives Products - Equity Options 8 | ||||||||||||||||||||||||
NYSE Group Options Contracts | 2,086 | 2,418 | -13.7 | % | 41,725 | 50,786 | -17.8 | % | 41,725 | -17.8 | % | |||||||||||||
Total Consolidated Options Contracts | 11,974 | 15,656 | -23.5 | % | 239,490 | 328,781 | -27.2 | % | 239,490 | -27.2 | % | |||||||||||||
NYSE Group Share of Total | 17.4 | % | 15.4 | % | 17.4 | % | 15.4 | % | 17.4 | % | 2.0 | % |
1 | Includes all volume executed in NYSE Group crossing sessions. | |
2 | Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. | |
3 | Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. | |
4 | Represents NYSE's volume in FINRA/NYSE Trade Reporting Facility (TRF). | |
5 | Data included in previously identified categories. | |
6 | Data includes currency products. | |
7 |
Includes all trading activities for Bclear, Euronext.liffe's clearing service for wholesale equity derivatives. | |
8 | Includes trading in U.S. equity options contracts, not equity-index options. | |
Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. | ||
All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells. | ||
US Equities data has been updated for Amex integration for October 2008 forward. |